LU87456A1 - Preparation de tetrazoles antihypercholesterolemiques et de leurs intermediaires - Google Patents

Preparation de tetrazoles antihypercholesterolemiques et de leurs intermediaires Download PDF

Info

Publication number
LU87456A1
LU87456A1 LU87456A LU87456A LU87456A1 LU 87456 A1 LU87456 A1 LU 87456A1 LU 87456 A LU87456 A LU 87456A LU 87456 A LU87456 A LU 87456A LU 87456 A1 LU87456 A1 LU 87456A1
Authority
LU
Luxembourg
Prior art keywords
radical
formula
compound
alkyl
united
Prior art date
Application number
LU87456A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU87456A1 publication Critical patent/LU87456A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)
LU87456A 1988-02-18 1989-02-17 Preparation de tetrazoles antihypercholesterolemiques et de leurs intermediaires LU87456A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/156,865 US4824959A (en) 1988-02-18 1988-02-18 Intermediates for antihypercholesterolemic tetrazole compounds
US15686588 1988-02-18

Publications (1)

Publication Number Publication Date
LU87456A1 true LU87456A1 (fr) 1989-09-20

Family

ID=22561419

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87456A LU87456A1 (fr) 1988-02-18 1989-02-17 Preparation de tetrazoles antihypercholesterolemiques et de leurs intermediaires

Country Status (32)

Country Link
US (1) US4824959A (ja)
JP (2) JP2871707B2 (ja)
KR (1) KR970002233B1 (ja)
CN (1) CN1025619C (ja)
AT (1) AT401057B (ja)
AU (1) AU621586B2 (ja)
BE (1) BE1002136A5 (ja)
CA (1) CA1340430C (ja)
CH (1) CH680792A5 (ja)
CY (1) CY1874A (ja)
DD (4) DD285603A5 (ja)
DE (1) DE3904899A1 (ja)
DK (1) DK75289A (ja)
EG (1) EG19217A (ja)
ES (1) ES2017810A6 (ja)
FI (1) FI890725A (ja)
FR (1) FR2630112B1 (ja)
GB (1) GB2216121B (ja)
GR (1) GR1000664B (ja)
HK (3) HK129295A (ja)
HU (2) HU204045B (ja)
IE (1) IE65090B1 (ja)
IT (1) IT1230750B (ja)
LU (1) LU87456A1 (ja)
MY (1) MY106279A (ja)
NL (1) NL8900397A (ja)
NO (1) NO172439C (ja)
NZ (1) NZ227935A (ja)
PT (1) PT89748B (ja)
SE (2) SE503179C2 (ja)
YU (1) YU34189A (ja)
ZA (1) ZA891239B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741509A1 (de) * 1987-12-08 1989-06-22 Hoechst Ag Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte
GB2244706B (en) * 1988-02-18 1992-07-15 Bristol Myers Co Preparation of antihypercholesterolemic tetrazole intermediates
US5010205A (en) * 1988-08-23 1991-04-23 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl intermediates
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
DE4128345C1 (en) * 1991-08-27 1993-06-09 Hoechst Ag, 6230 Frankfurt, De 3R,5S 3,5,6-tri:hydroxy-hexanoic acid isopropylidene ketal derivs. prepn. - from 7-benzyl:oxy 4,6-di:hydroxy:heptene by multistage process
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
CA2137049A1 (en) * 1993-12-15 1995-06-16 John K. Thottathil Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
DE10147030A1 (de) * 2001-09-04 2003-03-27 Forschungszentrum Juelich Gmbh Verfahren zur Trennung diastereomerer 1,3-Diol-Acetale
US20050272808A1 (en) * 2004-05-11 2005-12-08 Nadav Zamir Compositions and methods for the treatment of hypertension
WO2005107739A1 (en) * 2004-05-11 2005-11-17 Darley Pharmaceuticals Ltd. Spiroderivatives for the treatment of hypertension
CN104303915B (zh) * 2014-08-25 2016-05-25 李世峰 一种机插水稻水浮式育秧技术

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58225085A (ja) * 1982-06-24 1983-12-27 Nippon Kayaku Co Ltd アセタ−ルグリコ−ルジアクリレ−トおよびその製造法
US4808621A (en) * 1986-07-07 1989-02-28 Warner-Lambert Company Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4837205A (en) * 1986-09-02 1989-06-06 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4751229A (en) * 1987-07-09 1988-06-14 Warner-Lambert Company Treating fungal infections with substituted-(6-(tetrahydro-4-hydroxy-2-oxo-2H-pyran-2-yl)ethyl)- or ethenyl)pyrazoles
DE3807929A1 (de) * 1988-03-10 1989-09-28 Basf Ag Verfahren zur herstellung von reliefformen

Also Published As

Publication number Publication date
ZA891239B (en) 1991-12-24
CN1036013A (zh) 1989-10-04
FR2630112B1 (fr) 1994-07-29
HUT50167A (en) 1989-12-28
HK129295A (en) 1995-08-24
KR890012992A (ko) 1989-09-20
NO172439C (no) 1993-07-21
SE8900565D0 (sv) 1989-02-17
ATA36189A (de) 1995-10-15
DE3904899A1 (de) 1989-08-31
CH680792A5 (ja) 1992-11-13
AU3007589A (en) 1989-08-24
DK75289D0 (da) 1989-02-17
FI890725A (fi) 1989-08-19
SE503179C2 (sv) 1996-04-15
NO890661L (no) 1989-08-21
SE9300595A0 (sv) 1993-02-23
IT1230750B (it) 1991-10-29
BE1002136A5 (fr) 1990-07-24
HU209905B (en) 1994-11-28
GB8903604D0 (en) 1989-04-05
EG19217A (en) 1995-09-30
NO890661D0 (no) 1989-02-16
NL8900397A (nl) 1989-09-18
IE890523L (en) 1989-08-18
FR2630112A1 (fr) 1989-10-20
GB2216121A (en) 1989-10-04
FI890725A0 (fi) 1989-02-15
PT89748A (pt) 1989-10-04
PT89748B (pt) 1994-05-31
NZ227935A (en) 1990-07-26
SE9300595D0 (sv) 1993-02-23
CY1874A (en) 1996-04-05
JPH115791A (ja) 1999-01-12
JPH01249771A (ja) 1989-10-05
HUT50809A (en) 1990-03-28
GR1000664B (el) 1992-09-25
MY106279A (en) 1995-04-29
ES2017810A6 (es) 1991-03-01
DD285602A5 (de) 1990-12-19
NO172439B (no) 1993-04-13
HK129395A (en) 1995-08-24
AU621586B2 (en) 1992-03-19
JP2922887B2 (ja) 1999-07-26
DD283618A5 (de) 1990-10-17
CA1340430C (en) 1999-03-09
IE65090B1 (en) 1995-10-04
DD285600A5 (de) 1990-12-19
SE8900565L (sv) 1989-08-19
AT401057B (de) 1996-06-25
JP2871707B2 (ja) 1999-03-17
US4824959A (en) 1989-04-25
CN1025619C (zh) 1994-08-10
DK75289A (da) 1989-08-19
DD285603A5 (de) 1990-12-19
YU34189A (en) 1991-02-28
HK47596A (en) 1996-03-29
GB2216121B (en) 1992-07-15
HU204045B (en) 1991-11-28
IT8919474A0 (it) 1989-02-17
KR970002233B1 (ko) 1997-02-26

Similar Documents

Publication Publication Date Title
LU87456A1 (fr) Preparation de tetrazoles antihypercholesterolemiques et de leurs intermediaires
HU204038B (en) Process for producing tetrazole derivatives lowering pathologically high cholesterol level of blood
HU207856B (en) Process for producing /2r,3r/-cys-beta-phenyl-glycidic acid
Alcón et al. Enantioselective synthesis of (S)-vigabatrin®
Bartels et al. A selectivity study of activated ketal reduction with borane dimethyl sulfide
JPS5916881A (ja) 血糖低下活性を有する、脂環式置換されたオキサゾリジン−２，４−ジオン
LU86012A1 (fr) Nouveaux composes naphtaleniques,leur preparation et leur application comme medicaments
US4898950A (en) Preparation of antihypercholesterolemic tetrazole compounds
IE63205B1 (en) 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyheptanoic acids, their corresponding Delta-lactones and salts, processes for their preparation, their use as medicaments, pharmaceutical products and intermediates
LU87143A1 (fr) Intermediaires et procedes pour la preparation de tetrazoles antihypercholesterolemiques
GB2244706A (en) Tetrazole intermediates
FI103886B (fi) Menetelmä aldehydivälituotteen valmistamiseksi
US4920106A (en) Acetylenic cyclic carbonates
JP2680231B2 (ja) 光学活性２４―ヒドロキシコレステロール類の製造法
IL105486A (en) Intermediate compounds for the preparation of anti-hypercholesterolemic compounds
JP3247243B2 (ja) 光学活性２４―ヒドロキシ―２２，２３―ジデヒドロコレステロール類の製造法
IE65548B1 (en) Preparation of antihypercholesterolemic tetrazole compounds and intermediates thereof
JP2002114749A (ja) 光学活性２−ヒドロキシ−３−フェニルプロピオニトリル誘導体の製造法
Walker et al. Synthesis of 2, 5-dihydrofurans via alkylidene carbene insertion reactions
FR2701477A1 (fr) Nouveaux composés (cyclohexyl)alcéniques, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
JPH04316538A (ja) 光学活性３，５−アンチ−ジヒドロキシカルボン酸エステル誘導体の製造法
JPH0225895B2 (ja)
JPH01230536A (ja) 光学分割されたペンチトールまたはそのエステルの製造法
NO174850B (no) 6-(4,4-bis(substituert eller usubstituert fenyl)-3-(1-metyl-1H-tetrazol-5-yl)-1,3-butadienyl)-2,2-disubstituert-1,3-dioxan-4-eddiksyre eller et metallsalt derav